Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01142466 |
|---|---|
| Brief Title: | A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After Mitoxantrone (REMAIN) |
| First Submitted : | June 10, 2010 |
| First Submitted that Met QC Criteria : | June 10, 2010 |
| First Posted : | June 11, 2010 (Estimate) |
| Results First Submitted : | April 7, 2011 |
| Results First Submitted that Met QC Criteria : | May 11, 2011 |
| Results First Posted : | June 10, 2011 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 26, 2014 |
| Last Update Posted : | February 27, 2014 (Estimate) |